Illumina Australia

Today’s genomic solutions for tomorrow’s cancer breakthroughs.

An expanding next-generation sequencing (NGS) oncology portfolio is helping Illumina drive the revolution in cancer genomics.

Improve your clinical cancer research—and the potential impact of your work

Cutting-edge clinical cancer research solutions from Illumina deliver the accurate information your lab needs to improve the quality of your reporting and optimize—and even personalize—care. Rapidly analyze expert-defined genes and mutation hotspots to find actionable variants in any type of cancer, including solid tumors and hematological malignancies.

Our complete, seamless workflow solutions for translational cancer research include both fixed and customizable cancer panels and a comprehensive range of systems that can be scaled to meet your needs. Our multi-analyte approach enables you to get thorough information even from small specimens. In addition, these integrated solutions include data analysis and reporting capabilities to help you communicate significant findings effectively.